CSIMarket
 
Vivos Therapeutics Inc   (VVOS)
Other Ticker:  
 
 
Price: $4.4700 $-0.08 -1.758%
Day's High: $4.7351 Week Perf: -2.83 %
Day's Low: $ 4.11 30 Day Perf: -8.96 %
Volume (M): 75 52 Wk High: $ 48.79
Volume (M$): $ 333 52 Wk Avg: $8.01
Open: $4.61 52 Wk Low: $2.73



 Market Capitalization (Millions $) 5
 Shares Outstanding (Millions) 1
 Employees -
 Revenues (TTM) (Millions $) 14
 Net Income (TTM) (Millions $) -15
 Cash Flow (TTM) (Millions $) -6
 Capital Exp. (TTM) (Millions $) 1

Vivos Therapeutics Inc
Vivos Therapeutics Inc is a medical technology company that specializes in treating obstructive sleep apnea (OSA) and other sleep-disordered breathing conditions. The company has developed a unique treatment approach called the Vivos System, which focuses on non-surgical, non-pharmaceutical methods to address the underlying causes of sleep apnea.

The Vivos System aims to remodel and enhance the patient's upper airway through the use of proprietary oral appliances. These appliances are custom-designed based on each individual's unique anatomy and are intended to widen the upper airway, leading to improved breathing during sleep.

The company's treatment approach is grounded in the concept of craniofacial growth and development, recognizing that deficiencies in facial and airway structures can contribute to sleep-disordered breathing. By utilizing a multidisciplinary approach involving dentists, orthodontists, and physicians, Vivos Therapeutics seeks to provide a comprehensive treatment solution for patients with sleep apnea.

Vivos Therapeutics Inc aims to address the significant unmet need for alternative treatments to the standard continuous positive airway pressure (CPAP) therapy, which can be cumbersome and uncomfortable for some patients. The company's technology has shown promise in clinical studies, with patients reporting significant improvements in sleep quality and reduction in sleep apnea symptoms.

In summary, Vivos Therapeutics Inc is a medical technology company that offers a unique non-surgical treatment approach for obstructive sleep apnea, focusing on enhancing the upper airway through custom-designed oral appliances.


   Company Address: 7921 Southpark Plaza Littleton 80120 CO
   Company Phone Number: 908-4867   Stock Exchange / Ticker: NASDAQ VVOS
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Product Service News

Vivos Therapeutics Poised for Market Expansion amidst Favorable Medical Policies and Ongoing CPAP Device Recalls

Published Tue, Feb 6 2024 12:30 PM UTC

Healthcare innovation firm, Vivos Therapeutics, is experiencing a fortuitous upward trajectory in the market, spurred by recent developments with significant implications for the future of oral appliance therapies and sleep apnea technology. These developments include the reconsideration of medical policies by United Healthcare and widespread recalls of CPAP devices by estee...

Licensing Agreement

Vivos Therapeutics Triumphs With Groundbreaking FDA 510(k) Clearance, Revolutionizing Treatment for Severe OSA

Published Mon, Jan 8 2024 12:30 PM UTC

In a groundbreaking development, Vivos Therapeutics has achieved a significant milestone with the issuance of a FDA 510(k) clearance for its CARE oral medical devices designed to treat severe Obstructive Sleep Apnea (OSA). This achievement marks a paradigm shift in the field of sleep medicine, as Vivos Therapeutics has successfully paved the way for a non-invasive and highly...

Shares

Vivos Therapeutics Secures $4 Million Private Placement, Fuels Growth Opportunities

Published Thu, Nov 2 2023 9:00 PM UTC



Vivos Therapeutics, a leading medical technology company specializing in innovative treatments for patients with dentofacial abnormalities and mild-to-moderate obstructive sleep apnea (OSA) and snoring in adults, recently announced the successful closure of a $4 million private placement. This significant capital infusion, following the company's previous announcem...

Shares

Vivos Therapeutics Secures Funding for Innovative Sleep Apnea Treatments and Dentofacial Abnormalities Research through Private Placement

Published Tue, Oct 31 2023 12:01 PM UTC

Vivos Therapeutics Raises Funds for Innovative Dentofacial Abnormalities and Sleep Apnea Treatments through Private Placement
Littleton, Colo. - Vivos Therapeutics, a leading medical technology company dedicated to developing groundbreaking treatments for patients with dentofacial abnormalities and mild-to-moderate obstructive sleep apnea (OSA) and snoring in adults, ann...

Shares

Vivos Therapeutics Implements Bold Strategy: Reverse Stock Split to Transform Share Value Amidst Market Challenges

Published Thu, Oct 26 2023 11:30 AM UTC



Vivos Therapeutics, a leading healthcare company focused on treating sleep-related breathing disorders, has recently announced a significant move to enhance its financial position. The company will proceed with a 1-for-25 reverse stock split, a decision that could potentially impact the value and perception of its shares. This article aims to outline the facts surr...






 

Vivos Therapeutics Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com